Article
Race in Research: From Subjects to Scientists, ONS Scholar-in-Residence Has a Career Commitment to Racial Equity
“If we’re not driving our own research agenda and we’re not asking the questions we see as important, we are not realizing the full potential of nursing. We know, because we are with patients, what the issues are for patients, for families, and for communities. We have to be able to say, ‘Nope, this is the question.’” Margaret (Peg) Rosenzweig, PhD, FNP-BC, AOCNP®, ONS’s scholar-in-residence and professor at the University of Pittsburgh in Pennsylvania, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, oncology clinical specialist at ONS, during a discussion about her oncology nursing clinical and research career, commitment to equity, and role as ONS’s scholar-in-residence.
Related Topics
You May Also Like
Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
Article
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Article